ESOPMay 1, 2026, 05:32 PM
Zentalis Grants 26,000 Stock Options to New Employee
AI Summary
Zentalis Pharmaceuticals, Inc. announced that its Compensation Committee granted non-qualified stock options to purchase 26,000 shares of common stock to one newly hired employee on May 1, 2026. These options were issued under the 2022 Employment Inducement Incentive Award Plan as an inducement for employment, in accordance with Nasdaq Listing Rule 5635(c)(4). The exercise price is $4.09 per share, and the options will vest over four years.
Key Highlights
- Zentalis granted 26,000 non-qualified stock options to one newly hired employee.
- Options were issued under the 2022 Employment Inducement Incentive Award Plan.
- The exercise price is $4.09 per share, matching the closing price on the grant date.
- Options have a 10-year term and vest over four years.
- 25% of options vest on the first anniversary, with the remaining 75% vesting monthly over three years.
- The grant was made as an inducement for employment, per Nasdaq Listing Rule 5635(c)(4).
Price Impact
More from ZNTL